These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 25119976)

  • 1. Treating the violent patient with psychosis or impulsivity utilizing antipsychotic polypharmacy and high-dose monotherapy.
    Morrissette DA; Stahl SM
    CNS Spectr; 2014 Oct; 19(5):439-48. PubMed ID: 25119976
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Akathisia and second-generation antipsychotic drugs.
    Kumar R; Sachdev PS
    Curr Opin Psychiatry; 2009 May; 22(3):293-99. PubMed ID: 19378382
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Switching from oral atypical antipsychotic monotherapy to paliperidone palmitate once-monthly in non-acute patients with schizophrenia: A prospective, open-label, interventional study.
    Schreiner A; Caspi A; Bergmans P; Cherubin P; Keim S; Lara E; Pinchuk I; Schuepbach D; Suleman S; Hargarter L
    Psychopharmacology (Berl); 2017 Jan; 234(1):3-13. PubMed ID: 27815602
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quetiapine versus other atypical antipsychotics for schizophrenia.
    Asmal L; Flegar SJ; Wang J; Rummel-Kluge C; Komossa K; Leucht S
    Cochrane Database Syst Rev; 2013 Nov; (11):CD006625. PubMed ID: 24249315
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Equivalent occupancy of dopamine D1 and D2 receptors with clozapine: differentiation from other atypical antipsychotics.
    Tauscher J; Hussain T; Agid O; Verhoeff NP; Wilson AA; Houle S; Remington G; Zipursky RB; Kapur S
    Am J Psychiatry; 2004 Sep; 161(9):1620-5. PubMed ID: 15337652
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Real-world adherence assessment of lurasidone and other oral atypical antipsychotics among patients with schizophrenia: an administrative claims analysis.
    Rajagopalan K; Wade S; Meyer N; Loebel A
    Curr Med Res Opin; 2017 May; 33(5):813-820. PubMed ID: 28098496
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence and risk factors of acute akathisia in 493 individuals with first episode non-affective psychosis: a 6-week randomised study of antipsychotic treatment.
    Juncal-Ruiz M; Ramirez-Bonilla M; Gomez-Arnau J; Ortiz-Garcia de la Foz V; Suarez-Pinilla P; Martinez-Garcia O; Neergaard KD; Tabares-Seisdedos R; Crespo-Facorro B
    Psychopharmacology (Berl); 2017 Sep; 234(17):2563-2570. PubMed ID: 28567698
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Health Care Cost in Patients With Schizophrenia Treated With Brexpiprazole Versus Other Oral Atypical Antipsychotic Therapy.
    Yan T; Greene M; Chang E; Houle CR; Waters HC; Tarbox MH; Broder MS
    Clin Ther; 2020 Jan; 42(1):77-93. PubMed ID: 31928831
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacology of antipsychotics in the elderly: a focus on atypicals.
    Finkel S
    J Am Geriatr Soc; 2004 Dec; 52(12 Suppl):S258-65. PubMed ID: 15541166
    [No Abstract]   [Full Text] [Related]  

  • 10. Antipsychotics in pregnancy.
    McCauley-Elsom K; Gurvich C; Elsom SJ; Kulkarni J
    J Psychiatr Ment Health Nurs; 2010 Mar; 17(2):97-104. PubMed ID: 20465753
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence-Based Review of Pharmacotherapy Used for Parkinson's Disease Psychosis.
    Wilby KJ; Johnson EG; Johnson HE; Ensom MHH
    Ann Pharmacother; 2017 Aug; 51(8):682-695. PubMed ID: 28385039
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacological Treatment of Early-Onset Schizophrenia: A Critical Review, Evidence-Based Clinical Guidance and Unmet Needs.
    Lopez-Morinigo JD; Leucht S; Arango C
    Pharmacopsychiatry; 2022 Sep; 55(5):233-245. PubMed ID: 35777418
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Naturalistic studies of second generation antipsychotics in the treatment of schizophrenia.
    Sebastian CS; Glazer W; Buckley PF
    Curr Med Chem; 2004 Feb; 11(3):329-42. PubMed ID: 14965235
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A model of anticholinergic activity of atypical antipsychotic medications.
    Chew ML; Mulsant BH; Pollock BG; Lehman ME; Greenspan A; Kirshner MA; Bies RR; Kapur S; Gharabawi G
    Schizophr Res; 2006 Dec; 88(1-3):63-72. PubMed ID: 16928430
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Continuation of Atypical Antipsychotic Medication During Early Pregnancy and the Risk of Gestational Diabetes.
    Park Y; Hernandez-Diaz S; Bateman BT; Cohen JM; Desai RJ; Patorno E; Glynn RJ; Cohen LS; Mogun H; Huybrechts KF
    Am J Psychiatry; 2018 Jun; 175(6):564-574. PubMed ID: 29730938
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antipsychotic polypharmacy, Part 1: Therapeutic option or dirty little secret?
    Stahl SM
    J Clin Psychiatry; 1999 Jul; 60(7):425-6. PubMed ID: 10453794
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hospitalization risk in patients with schizophrenia treated with dose-equivalent antipsychotics.
    Ng-Mak D; Messali A; Huang A; Wang L; Loebel A
    Am J Manag Care; 2019 Jul; 25(14 Suppl):S279-S286. PubMed ID: 31365818
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diabetic ketoacidosis associated with antipsychotic drugs: case reports and a review of literature.
    Vuk A; Kuzman MR; Baretic M; Osvatic MM
    Psychiatr Danub; 2017 Jun; 29(2):121-135. PubMed ID: 28636569
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Atypical antipsychotics: special formulations for acute agitation.
    Howland RH
    J Psychosoc Nurs Ment Health Serv; 2005 Oct; 43(10):14-7. PubMed ID: 16294833
    [No Abstract]   [Full Text] [Related]  

  • 20. Treatment of psychosis: 30 years of progress.
    De Oliveira IR; Juruena MF
    J Clin Pharm Ther; 2006 Dec; 31(6):523-34. PubMed ID: 17176358
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.